Serum levels of SOD and risk of autism spectrum disorder: A case-control study

International Journal of Developmental Neuroscience

Volumn 51, Issue , 2016, Pages 12-16

  Wang, Lixuan ^a   Jia, Jianpu ^a   Zhang, Junling ^a   Li, Kuo ^a  

^a CANGZHOU CENTRAL HOSPITAL   (China)

Author keywords

Autism spectrum disorders; Oxidative stress; Risk; Superoxide dismutase

Indexed keywords

BIOLOGICAL MARKER; SUPEROXIDE DISMUTASE;

ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CHILD DEVELOPMENT; CHILDHOOD AUTISM RATING SCALE SCORE; CLINICAL INDICATOR; COLORIMETRY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; BLOOD; INFANT; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

AUTISM SPECTRUM DISORDER; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; REGRESSION ANALYSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SUPEROXIDE DISMUTASE;

EID: 84964344343     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2016.04.004     Document Type: Article

References (34)

1. Al-Gadani Y., El-Ansary A., Attas O., et al. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin. Biochem. 2009, 42(10):1032-1040.
2. Basso M., Ratan R.R. Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block. J. Cereb. Blood Flow Metab. 2013, 33(6):809-818.
3. Bechara E.G., Didiot M.C., Melko M., Davidovic L., Bensaid M., Martin P., et al. A novel function for fragile X mental retardation protein in translational activation. PLoS Biol. 2009, 7(1):e16.
4. Brigandi S.A., Shao H., Qian S.Y., et al. Autistic children exhibit decreased levels of essential fatty acids in red blood cells. Int. J. Mol. Sci. 2015, 16(5):10061-10076.
5. Cai J., Ding L., Zhang J.S., et al. Elevated plasma levels of glutamate in children with autism spectrum disorders. NeuroReport 2016, 27(4):272-276.
6. Chauhan A., Chauhan V. Oxidative stress in autism. Pathophysiology 2006, 13(3):171-181.
7. Chauhan A., Chauhan V. Increased Vulnerability to Oxidative Stress and Mitochondrial Dysfunction in Autism[M]//The Molecular Basis of Autism 2015, 407-425. Springer, New York.
8. Chlebowski C., Green J.A., Barton M.L., et al. Using the childhood autism rating scale to diagnose autism spectrum disorders. J. Autism Dev. Disord. 2010, 40(7):787-799.
9. Essa M.M., Braidy N., Vijayan K.R., et al. Excitotoxicity in the pathogenesis of autism. Neurotoxic. Res. 2013, 23(4):393-400.
10. Ghezzo A., Visconti P., Abruzzo P.M., et al. Oxidative stress and erythrocyte membrane alterations in children with autism: correlation with clinical features. PLoS One 2013, 8(6):e66418.
11. Gonzalez-Fraguela M.E., Hung M.L.D., Vera H., et al. Oxidative stress markers in children with autism spectrum disorders. Free Radic. Biol. Med. 2012, 53:S21.
12. Guney E., Ceylan M.F., Tektas A., et al. Oxidative stress in children and adolescents with anxiety disorders. J. Affect. Disord. 2014, 156:62-66.
13. Kandemir H., Abuhandan M., Aksoy N., et al. Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder. J. Psychiatr. Res. 2013, 47(11):1831-1834.
14. Krakowiak P., Goines P E., Tancredi D J., et al. Neonatal cytokine profiles associated with autism spectrum disorder. Biol. Psychiatry 2015, (Epub ahead of print). 10.1016/j.biopsych.2015.08.007.
15. Laszlo A., Novak Z., Szollosi-Varga I., Hai du Q., Vetro A., Kovacs A. Blood lipid peroxidation, antioxidant enzyme activities and hemorheological changes in autistic children. Ideggyogy Sz 2013, 66(1-2):23-28.
16. Mandell D., Lecavalier L. Should we believe the centers for Disease Control and Prevention's autism spectrum disorder prevalence estimates?. Autism 2014, 18(5):482-484.
17. McPartland J.C., Reichow B., Volkmar F.R. Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder. J. Am. Acad. Child Adolesc. Psychiatry 2012, 51(4):368-383.
18. Meng W.D., Sun S.J., Yang J., et al. Elevated serum brain-derived neurotrophic factor (BDNF) but not BDNF gene Val66Met polymorphism is associated with autism spectrum disorders. Mol. Neurobiol. 2016, [First online]. 10.1007/s12035-016-9721-9.
19. Mostafa G.A., El-Hadidi E.S., Hewedi D.H., et al. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J. Neuroimmunol. 2010, 219(1):114-118.
20. Mostafa G.A., Bjørklund G., Urbina M.A., et al. The levels of blood mercury and inflammatory-related neuropeptides in the serum are correlated in children with autism spectrum disorder. Metab. Brain Dis. 2016, [First online]. 10.1007/s11011-015-9784-8.
21. Napoli E., Wong S., Giulivi C. Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism. Mol. Autism 2013, 4(1):1.
22. Nunes S.O.V., Vargas H.O., Prado E., et al. The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence. Neurosci. Biobehav. Rev. 2013, 37(8):1336-1345.
23. Rose S., Melnyk S., Pavliv O., et al. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl. Psychiatry 2012, 2(7):e134.
24. Rossignol D.A., Frye R.E. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol. Psychiatry 2012, 17(4):389-401.
25. Rossignol D.A., Frye R.E. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 2012, 17(3):290-314.
26. Smaga I., Niedzielska E., Gawlik M., et al. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression: anxiety, schizophrenia and autism. Pharmacol. Rep. 2015, 67(3):569-580.
27. Sogut S., Zoroglu S.S., Ozyurt H., Yilmaz H.R., Ozugurlu F., Sivasli E., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin. Chim. Acta 2003, 331(1-2):111-117.
28. Sutti S., Jindal A., Locatelli I., et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology 2014, 59(3):886-897.
29. Tamari Y., Nawata H., Inoue E., et al. Protective roles of ascorbic acid in oxidative stress induced by depletion of superoxide dismutase in vertebrate cells. Free Radic. Res. 2013, 47(1):1-7.
30. Tu W., Yin C., Guo Y., et al. Serum homocysteine concentrations in Chinese children with autism. Clin. Chem. Lab. Med. 2013, 51(2):e19--e22.
31. Vergani L., Cristina L., Paola R., Luisa A.M., Shyti G., Edvige V., et al. Metals, metallothioneins and oxidative stress in blood of autistic children. Res. Autism Spectr. Disord 2011, 5(1):286-293.
32. Wu J.Q., Tan Y.L., Tan S.P., et al. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity. Schizophr. Res. 2014, 152(1):210-216.
33. Yorbik O., Sayal A., Akay C., Akbiyik D.I., Sohmen T. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot. Essent. Fatty Acids 2002, 67(5):341-343.
34. Zhang Q., Gao S., Zhao H. Thioredoxin: a novel, independent diagnosis marker in children with autism. Int. J. Dev. Neurosci. 2015, 40:92-96.